Adipositas

EU-Zulassung für Semaglutid-Tablette: 17% Gewichtsverlust, aber strikte Einnahme

by

The European Medicines Agency (EMA) and regulatory bodies worldwide are closely monitoring the clinical development of oral semaglutide for weight management, a treatment that has demonstrated significant potential in clinical trials such as the OASIS program. While the injectable version of the GLP-1 receptor agonist is already established, the oral formulation requires strict adherence to … Read more

Real-World Study Reveals: Significant Weight Loss from GLP-1 & GLP-1/GIP Therapies Dramatically Reduces Risk of Complications-Including Sleep Apnea, Diabetes & More

by

Here is the verified, original article based on the provided context and strict adherence to the guidelines: New research confirms what many patients and physicians have long suspected: GLP-1 receptor agonists—widely prescribed for type 2 diabetes and obesity—are delivering more than just weight loss. A growing body of real-world evidence now links significant weight reduction … Read more

From 114 Pounds to Freedom: How One Man Lost Over 50% of His Weight & Reclaimed His Life – A Inspiring Weight Loss Transformation Story

by

Berlin, May 18, 2026 — The path from severe obesity to reclaiming one’s life is rarely straightforward. For a man from Herford, Germany, this journey began with a stark reality: “I could barely move.” After losing 114 kilograms through medical intervention and rigorous lifestyle changes, he is now sharing his story to inspire others facing … Read more

GLP-1 and Obesity Treatment: Metabolic Health, Long-Term Therapy, and Future Innovations

by

For decades, the global approach to treating obesity was framed primarily as a battle of willpower. Patients were told to “eat less and move more,” a mantra that often ignored the complex biological drivers of weight gain and the stubborn nature of metabolic adaptation. However, a pharmacological shift is currently underway, transforming obesity from a … Read more

Adipositas & Frauengesundheit: Risiken, PCOS, Schwangerschaft & Therapie | FOKO 2026 Insights

by

The Growing Interdisciplinary Challenge of Obesity and Women’s Health Obesity is increasingly recognized not just as a metabolic concern, but as a significant factor impacting all stages of a woman’s life, from reproductive health to long-term well-being. Recent discussions at the FOKO 2026 conference highlighted the complex interplay between weight and various health conditions, including … Read more

The Yo-Yo Effect: Understanding Weight Cycling & How to Break Free

by

The pursuit of weight loss has led many to explore medications like Ozempic and Wegovy, alongside older options‍ such as Orlistat and Fenfluramin.Increasingly, individuals are turning to these drugs to achieve their desired weight. Recent data from a report released in early 2026 indicates that the use⁣ of weight loss medications‍ in Germany has roughly … Read more